Skip to content
Home/Companies/Healthcare/Sanquin Reagents
Sanquin Reagents

Sanquin Reagents

Healthcare·Netherlands·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Sanquin Reagents?

Sanquin Reagents has LGT Private Debt on file as a lender through Crown European Private Debt III (2021 vintage), financing since 2022. Its equity owner is not tracked by GP Intel yet.

Hand-verified · updated 2026-05-31

LGT Private Debt
Investor
LGT Private Debt
Crown European Private Debt III · 2021 · Private Debt

Key facts

HQNetherlands
SectorHealthcare
StatusActive
Websitewww.essange-reagents.com

More from Crown European Private Debt III

Other portfolio companies in the same fund.

Eckoh
Eckoh
Active
SoftwareUK· 2025
Acteon
Active
MedTechFrance· 2024
Fulgard
Active
HealthcareItaly· 2024
HT Medica
Active
HealthcareSpain· 2024
Olyos
Olyos
Active
HealthcareFrance· 2022
Resilians
Active
ClimateTechFrance· 2021

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Track Sanquin Reagents

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Sanquin Reagents?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Sanquin Reagents.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue